Benzinga
09 Jan 2026, 15:58 UTC · 41w ago
Verdict
Headline leans bullish. We score INSM +0.80.
Score confirms the headline.
Leans bullish
From its wording — no explicit rating
+0.80strongly bullish
Which stocks this story touches
More positive than 88% of ticker scores this week
Positive traction due to strong Brinsupri revenues, European approval, and a robust pipeline of clinical trials.
Continue reading
5 related stories
More positive than 88% of ticker scores this week
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Seeking Alpha
7h ago
−33.8%
Price is moving against the score
$112.65 vs $170.27 close before publication (Jan 8) · not market-adjusted
INSM chart →
